Article: Schering-Plough Probe Wraps Up; New Jersey Drug Maker Won't Face Penalties.

By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News

Oct. 2--Schering-Plough Corp. can stop sweating another investigation.

The Kenilworth (NJ)-based drug maker announced Wednesday that the U.S. attorney's office in Newark (NJ) closed its investigation into products manufactured in Puerto Rico. No penalties were levied, said Robert Consalvo, a company spokesman.

Michael Drewniak, a spokesman for U.S. attorney Christopher Christie, confirmed the office had closed the case, saying it was "into whether Schering-Plough used improper pharmaceutical ingredients not approved for use in the United States." Drewniak ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!